{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T14:02:25Z","timestamp":1792245745544,"version":"4.4.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:p>Isavuconazole is a new azole approved for adults with invasive aspergillosis and mucormycosis, with a favorable hepatic tolerability reported in Phase III trials. Here, we report on a case of drug-induced liver failure related to isavuconazole in a pediatric patient treated for invasive aspergillosis after bone marrow transplant.<\/jats:p>","DOI":"10.1097\/inf.0000000000002418","type":"journal-article","created":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T09:10:46Z","timestamp":1568970646000},"page":"1035-1037","source":"Crossref","is-referenced-by-count":13,"title":["Isavuconazole-induced Acute Liver Failure in a Pediatric Patient With Invasive Aspergillosis"],"prefix":"10.1097","volume":"38","author":[{"given":"Erica","family":"Brivio","sequence":"first","affiliation":[{"name":"Pediatric Department, Ospedale San Gerardo, Fondazione MBBM, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Verna","sequence":"additional","affiliation":[{"name":"Pediatric Department, Ospedale San Gerardo, Fondazione MBBM, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guglielmo Marco","family":"Migliorino","sequence":"additional","affiliation":[{"name":"Infectious Disease Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Foresti","sequence":"additional","affiliation":[{"name":"Infectious Disease Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Zucchini","sequence":"additional","affiliation":[{"name":"Pathology department, Ospedale S. Gerardo, Monza, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attilio","family":"Rovelli","sequence":"additional","affiliation":[{"name":"Pediatric Department, Ospedale San Gerardo, Fondazione MBBM, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20240429","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2016.12.003","article-title":"EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure.","volume":"66","author":"Wendon","year":"2017","journal-title":"J Hepatol"},{"key":"R2-20240429","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1128\/AAC.45.12.3487-3496.2001","article-title":"Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study.","volume":"45","author":"Walsh","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"R3-20240429","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/hep.23937","article-title":"Drug-induced acute liver failure: results of a U.S. multicenter, prospective study.","volume":"52","author":"Reuben","year":"2010","journal-title":"Hepatology"},{"key":"R4-20240429","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/myc.12885","article-title":"Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: a retrospective comparison of rates of adverse events.","volume":"62","author":"Bongomin","year":"2019","journal-title":"Mycoses"},{"key":"R5-20240429","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00520-016-3412-y","article-title":"Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology.","volume":"25","author":"Morgan","year":"2017","journal-title":"Support Care Cancer"},{"key":"R6-20240429","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients.","volume":"102","author":"Tissot","year":"2017","journal-title":"Haematologica"},{"key":"R7-20240429","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"R8-20240429","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jpids\/piu074","article-title":"A prospective, international cohort study of invasive mold infections in children.","volume":"4","author":"Wattier","year":"2015","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R9-20240429","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","article-title":"Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial).","volume":"44","author":"Cornely","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R10-20240429","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/myc.12871","article-title":"Managing liver dysfunction in haematology patients: switch antifungals, or use the tincture of time?","volume":"62","author":"Perissinotti","year":"2019","journal-title":"Mycoses"},{"key":"R11-20240429","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000494329","article-title":"Isavuconazole: case report and pharmacokinetic considerations.","volume":"63","author":"Marchesi","year":"2018","journal-title":"Chemotherapy"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002418","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T18:11:01Z","timestamp":1714414261000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":11,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002418","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}